• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA IDL SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA IDL SET Back to Search Results
Model Number 12320
Device Problems Contamination of Device Ingredient or Reagent (2901); Adverse Event Without Identified Device or Use Problem (2993); Insufficient Information (3190)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/03/2021
Event Type  malfunction  
Manufacturer Narrative
Manufacture and expiry date are not available at this time.Investigation is in process.A follow-up report will be provided.
 
Event Description
The customer reported that a lymphopheresis collection was done on a patient that was totally asymptomatic and with no records on previous infections and negative autologous pre-donation serologies.A sterility culture performed to lymphocyte collected product resulted positive for serratia marcescens.Sample taken in a class ii safety biologic cabinet from tubing segment detached from mother collection bag (no other samples taken during or after procedure), closed system maintained all the time.Upon positive culture, and approximately 24 hours after collection, cvc (central venous catheter) was removed and samples were taken from patient for culture, resulting all negative.Patient identifier and outcome are unknown at this time.Terumo bct is awaiting return of the disposable set for evaluation.
 
Manufacturer Narrative
This report is being filed to provide additional information in h.6 and h.10.Investigation: the customer provided a microbiology test report to aid in the investigation.The report confirmed that the bacteria identified was serratia marcescens.A review of the device history record (dhr) for this unit showed no irregularities during manufacturing that were relevant to this issue.The customer indicated that the sample was taken in a class ii biosafety cabinet from the tubing segment detached from the collection bag.There were no other samples taken during or after the procedure, and a closed system was maintained at all time.The bacterial testing was performed using bruker daltonik maldi biotyper.Per literature review, serratia marcescens is a gram-negative bacillus that produces a red pigment at room temperature.Serratia are considered to be ubiquitous in the environment and the organism is found in water, soil, plants, insects, animals, mammals including humans and food, particularly those rich in starch.There is no evidence to suggest a malfunction of the disposable kit or the spectra optia device caused or contributed to the bacterial contamination.Based on the available information, a specific root cause for the reported bacterial contamination could not be determined.The product was terminally sterilized to a sterility assurance level (sal) of
 
Event Description
The customer reported that a lymphopheresis collection was done on a patient that was totally asymptomatic and with no records on previous infections and negative autologous pre-donation serologies.A sterility culture performed to lymphocyte collected product resulted positive for serratia marcescens.Sample taken in a class ii safety biologic cabinet from tubing segment detached from mother collection bag (no other samples taken during or after procedure), closed system maintained all the time.Positive bacterial contamination was detected 24 hours after collection and at that moment the patient was administered empiric antibiotics treatment and the patient¿s central venous catheter was removed.Cultures were taken from the patient for bacterial culture and all the results were negative.Patient identifier and outcome are unknown at this time.Terumo bct is awaiting return of the disposable set for evaluation.
 
Event Description
The customer reported that a lymphopheresis collection was done on a patient that was totally asymptomatic and with no records on previous infections and negative autologous pre-donation serologies.A sterility culture performed to lymphocyte collected product resulted positive for serratia marcescens.Sample taken in a class ii safety biologic cabinet from tubing segment detached from mother collection bag (no other samples taken during or after procedure), closed system maintained all the time.Positive bacterial contamination was detected 24 hours after collection and at that moment the patient was administered empiric antibiotics treatment and the patient¿s central venous catheter was removed.Cultures were taken from the patient for bacterial culture and all the results were negative.Patient identifier and outcome are unknown at this time.Terumo bct is awaiting return of the disposable set for evaluation.
 
Manufacturer Narrative
This report is being filed to provide additional information in b.5, d.3, h.4, h.6 and h.10.Investigation: the customer provided a microbiology test report to aid in the investigation.The report confirmed that the bacteria identified was serratia marcescens.A review of the device history record (dhr) for this unit showed no irregularities during manufacturing that were relevant to this issue.The customer indicated that the sample was taken in a class ii biosafety cabinet from the tubing segment detached from the collection bag.There were no other samples taken during or after the procedure, and a closed system was maintained at all time.The bacterial testing was performed using bruker daltonik maldi biotyper.Per literature review, serratia marcescens is a gram-negative bacillus that produces a red pigment at room temperature.Serratia are considered to be ubiquitous in the environment and the organism is found in water, soil, plants, insects, animals, mammals including humans and food, particularly those rich in starch.There is no evidence to suggest a malfunction of the disposable kit or the spectra optia device caused or contributed to the bacterial contamination.Based on the available information, a specific root cause for the reported bacterial contamination could not be determined.The product was terminally sterilized to a sterility assurance level (sal) of
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPECTRA OPTIA
Type of Device
SPECTRA OPTIA IDL SET
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
Manufacturer (Section G)
TERUMO BCT
10810 w. collins ave
lakewood CO 80215
Manufacturer Contact
scot hilden
10810 w. collins ave
lakewood, CO 80215
MDR Report Key13142584
MDR Text Key287672425
Report Number1722028-2022-00002
Device Sequence Number1
Product Code GKT
UDI-Device Identifier05020583123205
UDI-Public05020583123205
Combination Product (y/n)N
Reporter Country CodeSP
PMA/PMN Number
BK150251
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 01/03/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/03/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/01/2023
Device Model Number12320
Device Catalogue Number12320
Device Lot Number2015133330
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/10/2023
Was Device Evaluated by Manufacturer? No
Date Device Manufactured05/18/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
ACD-A; ACD-A; ACD-A
Patient Outcome(s) Other;
Patient Age46 YR
Patient SexMale
Patient Weight69 KG
-
-